(3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane

C155H319N25 — CID 167693685

IUPAC(3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane
SMILESC.CC(C)(C)N1CCN(CC2CC2)CC1.CC(C1CC1)N1C[C@@H]2CN(C(C)(C)C)C[C@@H]2C1.CCN1CCC2(CC1)CN(C(C)(C)C)C2.CCN1CCN(C(C)(C)C)CC1.CCN1C[C@@H]2CN(C(C)(C)C)C[C@]2(C)C1.CN(C)C1CCN(C(C)(C)C)CC1.CN(C)CC1CCN(C(C)(C)C)CC1.CN1CC2(CCN(C(C)(C)C)CC2)C1.CN1CCC(C(C)(C)C)CC1.CN1CCC2(CC1)CCN(C(C)(C)C)CC2.CN1CCC2(CC1)CN(C(C)(C)C)C2.CN1CCN(C(C)(C)C)CC1.CN1C[C@@H]2CN(C(C)(C)C)C[C@@H]2C1
InChIInChI=1S/C15H28N2.C14H28N2.2C13H26N2.3C12H24N2.C12H26N2.C11H22N2.C11H24N2.C10H22N2.C10H21N.C9H20N2.CH4/c1-11(12-5-6-12)16-7-13-9-17(15(2,3)4)10-14(13)8-16;1-13(2,3)16-11-7-14(8-12-16)5-9-15(4)10-6-14;1-6-14-7-11-8-15(12(2,3)4)10-13(11,5)9-14;1-5-14-8-6-13(7-9-14)10-15(11-13)12(2,3)4;1-11(2,3)14-7-5-12(6-8-14)9-13(4)10-12;1-11(2,3)14-9-12(10-14)5-7-13(4)8-6-12;1-12(2,3)14-8-6-13(7-9-14)10-11-4-5-11;1-12(2,3)14-8-6-11(7-9-14)10-13(4)5;1-11(2,3)13-7-9-5-12(4)6-10(9)8-13;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-5-11-6-8-12(9-7-11)10(2,3)4;1-10(2,3)9-5-7-11(4)8-6-9;1-9(2,3)11-7-5-10(4)6-8-11;/h11-14H,5-10H2,1-4H3;5-12H2,1-4H3;11H,6-10H2,1-5H3;5-11H2,1-4H3;2*5-10H2,1-4H3;11H,4-10H2,1-3H3;11H,6-10H2,1-5H3;9-10H,5-8H2,1-4H3;10H,6-9H2,1-5H3;5-9H2,1-4H3;9H,5-8H2,1-4H3;5-8H2,1-4H3;1H4/t11?,13-,14+;;11-,13+;;;;;;9-,10+;;;;;/m..1.........../s1
InChIKeyXIERIDQMWDVRGC-PXGSNRDCSA-N
MW2533.43 g/mol
LogP25.35
Rot. Bonds10

About (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane

(3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane (PubChem CID 167693685) has the molecular formula C155H319N25 and a molecular weight of 2533.43 g/mol. Its IUPAC name is (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane.

Molecular Properties

Compound Name(3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane
PubChem CID167693685
Molecular FormulaC155H319N25
Molecular Weight2533.43 g/mol
Exact Mass2531.57
IUPAC Name(3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane
SMILESC.CC(C)(C)N1CCN(CC2CC2)CC1.CC(C1CC1)N1C[C@@H]2CN(C(C)(C)C)C[C@@H]2C1.CCN1CCC2(CC1)CN(C(C)(C)C)C2.CCN1CCN(C(C)(C)C)CC1.CCN1C[C@@H]2CN(C(C)(C)C)C[C@]2(C)C1.CN(C)C1CCN(C(C)(C)C)CC1.CN(C)CC1CCN(C(C)(C)C)CC1.CN1CC2(CCN(C(C)(C)C)CC2)C1.CN1CCC(C(C)(C)C)CC1.CN1CCC2(CC1)CCN(C(C)(C)C)CC2.CN1CCC2(CC1)CN(C(C)(C)C)C2.CN1CCN(C(C)(C)C)CC1.CN1C[C@@H]2CN(C(C)(C)C)C[C@@H]2C1
InChIInChI=1S/C15H28N2.C14H28N2.2C13H26N2.3C12H24N2.C12H26N2.C11H22N2.C11H24N2.C10H22N2.C10H21N.C9H20N2.CH4/c1-11(12-5-6-12)16-7-13-9-17(15(2,3)4)10-14(13)8-16;1-13(2,3)16-11-7-14(8-12-16)5-9-15(4)10-6-14;1-6-14-7-11-8-15(12(2,3)4)10-13(11,5)9-14;1-5-14-8-6-13(7-9-14)10-15(11-13)12(2,3)4;1-11(2,3)14-7-5-12(6-8-14)9-13(4)10-12;1-11(2,3)14-9-12(10-14)5-7-13(4)8-6-12;1-12(2,3)14-8-6-13(7-9-14)10-11-4-5-11;1-12(2,3)14-8-6-11(7-9-14)10-13(4)5;1-11(2,3)13-7-9-5-12(4)6-10(9)8-13;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-5-11-6-8-12(9-7-11)10(2,3)4;1-10(2,3)9-5-7-11(4)8-6-9;1-9(2,3)11-7-5-10(4)6-8-11;/h11-14H,5-10H2,1-4H3;5-12H2,1-4H3;11H,6-10H2,1-5H3;5-11H2,1-4H3;2*5-10H2,1-4H3;11H,4-10H2,1-3H3;11H,6-10H2,1-5H3;9-10H,5-8H2,1-4H3;10H,6-9H2,1-5H3;5-9H2,1-4H3;9H,5-8H2,1-4H3;5-8H2,1-4H3;1H4/t11?,13-,14+;;11-,13+;;;;;;9-,10+;;;;;/m..1.........../s1
InChIKeyXIERIDQMWDVRGC-PXGSNRDCSA-N
XLogP25.35
TPSA81.00 Ų
H-Bond Donors
H-Bond Acceptors25
Rotatable Bonds10
Heavy Atoms180
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002533.43
LogP ≤ 525.35
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1025

Analyze (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane?
The IUPAC name of (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane (CID 167693685) is (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane.
What is the SMILES notation for (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane?
The canonical SMILES for (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane is C.CC(C)(C)N1CCN(CC2CC2)CC1.CC(C1CC1)N1C[C@@H]2CN(C(C)(C)C)C[C@@H]2C1.CCN1CCC2(CC1)CN(C(C)(C)C)C2.CCN1CCN(C(C)(C)C)CC1.CCN1C[C@@H]2CN(C(C)(C)C)C[C@]2(C)C1.CN(C)C1CCN(C(C)(C)C)CC1.CN(C)CC1CCN(C(C)(C)C)CC1.CN1CC2(CCN(C(C)(C)C)CC2)C1.CN1CCC(C(C)(C)C)CC1.CN1CCC2(CC1)CCN(C(C)(C)C)CC2.CN1CCC2(CC1)CN(C(C)(C)C)C2.CN1CCN(C(C)(C)C)CC1.CN1C[C@@H]2CN(C(C)(C)C)C[C@@H]2C1.
What is the InChIKey of (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane?
The InChIKey is XIERIDQMWDVRGC-PXGSNRDCSA-N. The full InChI is InChI=1S/C15H28N2.C14H28N2.2C13H26N2.3C12H24N2.C12H26N2.C11H22N2.C11H24N2.C10H22N2.C10H21N.C9H20N2.CH4/c1-11(12-5-6-12)16-7-13-9-17(15(2,3)4)10-14(13)8-16;1-13(2,3)16-11-7-14(8-12-16)5-9-15(4)10-6-14;1-6-14-7-11-8-15(12(2,3)4)10-13(11,5)9-14;1-5-14-8-6-13(7-9-14)10-15(11-13)12(2,3)4;1-11(2,3)14-7-5-12(6-8-14)9-13(4)10-12;1-11(2,3)14-9-12(10-14)5-7-13(4)8-6-12;1-12(2,3)14-8-6-13(7-9-14)10-11-4-5-11;1-12(2,3)14-8-6-11(7-9-14)10-13(4)5;1-11(2,3)13-7-9-5-12(4)6-10(9)8-13;1-11(2,3)13-8-6-10(7-9-13)12(4)5;1-5-11-6-8-12(9-7-11)10(2,3)4;1-10(2,3)9-5-7-11(4)8-6-9;1-9(2,3)11-7-5-10(4)6-8-11;/h11-14H,5-10H2,1-4H3;5-12H2,1-4H3;11H,6-10H2,1-5H3;5-11H2,1-4H3;2*5-10H2,1-4H3;11H,4-10H2,1-3H3;11H,6-10H2,1-5H3;9-10H,5-8H2,1-4H3;10H,6-9H2,1-5H3;5-9H2,1-4H3;9H,5-8H2,1-4H3;5-8H2,1-4H3;1H4/t11?,13-,14+;;11-,13+;;;;;;9-,10+;;;;;/m..1.........../s1.
What are the key properties of (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane?
(3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane has a molecular weight of 2533.43 g/mol, XLogP of 25.35, 10 rotatable bonds, 0 hydrogen bond donors, and 25 hydrogen bond acceptors.
Where does this data come from?
All data for (3aS,6aR)-5-tert-butyl-2-(1-cyclopropylethyl)-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-ethyl-3a-methyl-3,4,6,6a-tetrahydro-1H-pyrrolo[3,4-c]pyrrole;(3aS,6aR)-5-tert-butyl-2-methyl-1,3,3a,4,6,6a-hexahydropyrrolo[3,4-c]pyrrole;1-tert-butyl-4-(cyclopropylmethyl)piperazine;1-tert-butyl-N,N-dimethylpiperidin-4-amine;2-tert-butyl-7-ethyl-2,7-diazaspiro[3.5]nonane;1-tert-butyl-4-ethylpiperazine;2-tert-butyl-7-methyl-2,7-diazaspiro[3.5]nonane;7-tert-butyl-2-methyl-2,7-diazaspiro[3.5]nonane;3-tert-butyl-9-methyl-3,9-diazaspiro[5.5]undecane;1-tert-butyl-4-methylpiperazine;4-tert-butyl-1-methylpiperidine;1-(1-tert-butylpiperidin-4-yl)-N,N-dimethylmethanamine;methane is sourced from PubChem (CID 167693685), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).